4-(2-chloropyridin-4-yl)-N-(4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)pyrimidin-2-amine

ID: ALA5283441

Chembl Id: CHEMBL5283441

Max Phase: Preclinical

Molecular Formula: C21H20ClF3N6

Molecular Weight: 448.88

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ccc(Nc3nccc(-c4ccnc(Cl)c4)n3)cc2C(F)(F)F)CC1

Standard InChI:  InChI=1S/C21H20ClF3N6/c1-30-8-10-31(11-9-30)18-3-2-15(13-16(18)21(23,24)25)28-20-27-7-5-17(29-20)14-4-6-26-19(22)12-14/h2-7,12-13H,8-11H2,1H3,(H,27,28,29)

Standard InChI Key:  UWDRPHXOMMPVSE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5283441

    ---

Associated Targets(Human)

CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK4 Tclin CDK4/Cyclin D3 (681 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pknB Serine/threonine-protein kinase pknB (356 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 448.88Molecular Weight (Monoisotopic): 448.1390AlogP: 4.71#Rotatable Bonds: 4
Polar Surface Area: 57.18Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.66CX LogP: 4.64CX LogD: 4.19
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.58Np Likeness Score: -1.65

References

1. Wlodarchak N, Feltenberger JB, Ye Z, Beczkiewicz J, Procknow R, Yan G, King TM, Golden JE, Striker R..  (2021)  Engineering Selectivity for Reduced Toxicity of Bacterial Kinase Inhibitors Using Structure-Guided Medicinal Chemistry.,  12  (2.0): [PMID:35035774] [10.1021/acsmedchemlett.0c00580]

Source